Tyrosine kinase inhibitors combined with venetoclax and azacytidine as an effective therapy for de novo lymphoid blast phase-chronic myeloid leukemia

Autor: Yang, Zhihuan, Liu, Chunhua, Hu, Yimin, Liu, Hong, Li, Junfan, Wu, Lihua, Liu, Qingguo, Zheng, Yali, Huang, Pingping, Wang, Ying
Zdroj: In Leukemia Research April 2023 127
Databáze: ScienceDirect